e-Drug3D

777

ALBENDAZOLE


INN
ALBENDAZOLE

(has an active metabolite)

cas 54965-21-8
CLASS

ANTIPARASITIC
ANTHELMINTIC
ANTIPROTOZOAL AGENTS
TUBULIN MODULATORS
INHIBITORY EFFECT ON TUBULIN POLYMERIZATION
ANTIMALARIALS

ROUTE (list)

ORAL

ATC code

P02CA03

PK parameters

Solubility

PRACTICALLY INSOLUBLE IN WATER


Target

TARGET TUBULIN

DrugCentral

Tubulin UNIPROT C4PKY4

Tubulin UNIPROT F1L005

Download SDF file methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate

Formula:
C12H15N3O2S

Calculated chemical properties:

MW 265.34
NB_atoms 18
XLogP 3.24
PSA 60.783
NB_HD 2
NB_HA 5
fsp3 0.33
Lipinski(0=no;1=yes) 1

FDA
NDA 020666 (label) INN (ALBENDAZOLE) ALBENZA (IMPAX LABS INC) APPROVAL= AP YEAR= 1996 NEWMOLECULARENTITY DISCONTINUED
NDA 207844 (label) INN (ALBENDAZOLE) ALBENZA (AMEDRA PHARMS LLC) APPROVAL= AP YEAR= 2015 DISCONTINUED OBSOLETE
NDA 208979 (pdf not found) INN (ALBENDAZOLE) ALBENDAZOLE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2018
NDA 210011 (pdf not found) INN (ALBENDAZOLE) ALBENDAZOLE (STRIDES PHARMA) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 210434 (pdf not found) INN (ALBENDAZOLE) ALBENDAZOLE (CIPLA LTD) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 208094 (pdf not found) INN (ALBENDAZOLE) ALBENDAZOLE (ACTAVIS ELIZABETH) APPROVAL= AP YEAR= 2019
NDA 211117 (pdf not found) INN (ALBENDAZOLE) ALBENDAZOLE (EDENBRIDGE PHARMS) APPROVAL= AP YEAR= 2019
NDA 211636 (pdf not found) INN (ALBENDAZOLE) ALBENDAZOLE (CHARTWELL RX) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 211034 (pdf not found) INN (ALBENDAZOLE) ALBENDAZOLE (DR REDDYS) APPROVAL= AP YEAR= 2021
NDA 213435 (pdf not found) INN (ALBENDAZOLE) ALBENDAZOLE (MSN) APPROVAL= AP YEAR= 2021
NDA 215652 (pdf not found) INN (ALBENDAZOLE) ALBENDAZOLE (ALEMBIC) APPROVAL= AP YEAR= 2024

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL